Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening

BACKGROUND: Recent guidelines recommend consideration of germline testing for all newly diagnosed pancreatic ductal adenocarcinoma (PDAC). The primary aim of this study was to determine the burden of hereditary cancer susceptibility in PDAC. A secondary aim was to compare genetic testing uptake rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Cremin, Carol, Lee, Michael Kuan‐Ching, Hong, Quan, Hoeschen, Carolyn, Mackenzie, Anna, Dixon, Katherine, McCullum, Mary, Nuk, Jennifer, Kalloger, Steve, Karasinska, Joanna, Scudamore, Charles, Kim, Peter T. W., Donnellan, Fergal, Lam, Eric C. S., Lim, Howard J., Neben, Cynthia L., Stedden, Will, Zhou, Alicia Y., Schaeffer, David F., Sun, Sophie, Renouf, Daniel J., Schrader, Kasmintan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286471/
https://www.ncbi.nlm.nih.gov/pubmed/32255556
http://dx.doi.org/10.1002/cam4.2973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286471/
https://www.ncbi.nlm.nih.gov/pubmed/32255556
http://dx.doi.org/10.1002/cam4.2973

Ejemplares similares